Titre :
  • An exploratory analysis of the factors leading to delays in cancer drug reimbursement in the European Union: the trastuzumab case.
Auteur : Ades, F ; Senterre, Christelle ; Zardavas, Dimitros ; de Azambuja, Evandro E ; Popescu, Razvan R. ; Parent, Florence ; Piccart, Martine M
Informations sur la publication : European journal of cancer, 50, 18, (page 3089-3097)
Statut de publication : Publié, 2014-12
Sujet CREF : Cancérologie
Santé publique
Mots-clés : Breast cancer
Drug reimbursement
European Union
Health expenditure
Health policy
Trastuzumab
Mots-clés MeSH : Antibodies, Monoclonal, Humanized -- economics -- therapeutic use
Antineoplastic Agents -- economics -- therapeutic use
Breast Neoplasms -- drug therapy -- economics
Chemotherapy, Adjuvant -- economics
Cost-Benefit Analysis
Drug Approval -- economics
European Union -- economics
Female
Health Expenditures -- statistics & numerical data
Health Policy -- economics
Humans
Neoplasm Metastasis
Reimbursement Mechanisms
Time Factors
Langue :
  • Anglais
Identificateurs : urn:issn:0959-8049 
info:doi/10.1016/j.ejca.2014.09.011
info:pii/S0959-8049(14)00961-7
info:pmid/25446375